Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 24, 2026

Apr. 24, 2026

Media Advisory-Ontario Health Coalition/Large cross-province protests this Saturday: Ford gov’t pushing our hospitals into deficit & cuts while paying more to privatize their services

Indeterminate GlobeNewswire

Apr. 24, 2026

Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy

Indeterminate GlobeNewswire

Apr. 24, 2026

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®

Indeterminate GlobeNewswire

Apr. 24, 2026

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Indeterminate GlobeNewswire

Apr. 24, 2026

30 Years of Smiles: St. Augustine’s Premier Cosmetic Dentist Marks a Career Built on Artistry

Indeterminate GlobeNewswire

Apr. 24, 2026

Free Carotenoid Eye Screenings Offered to Seacoast Residents Near Portsmouth, NH

Indeterminate GlobeNewswire

Apr. 24, 2026

Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification

Indeterminate GlobeNewswire

Apr. 24, 2026

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Indeterminate GlobeNewswire

Apr. 24, 2026

Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

Indeterminate GlobeNewswire

Apr. 24, 2026

Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026

Indeterminate GlobeNewswire

Apr. 24, 2026

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

Indeterminate GlobeNewswire

Apr. 24, 2026

Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses

Indeterminate GlobeNewswire

Apr. 24, 2026

Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Indeterminate GlobeNewswire

Apr. 24, 2026

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

Indeterminate GlobeNewswire

Apr. 24, 2026

Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

Indeterminate GlobeNewswire

Apr. 24, 2026

Geneva College of Longevity Science Launches the World’s First PhD in Longevity Sciences

Indeterminate GlobeNewswire

Apr. 24, 2026

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

Indeterminate GlobeNewswire

Apr. 24, 2026

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

Indeterminate GlobeNewswire

Apr. 24, 2026

FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

Indeterminate GlobeNewswire